36.82
                                            Schlusskurs vom Vortag:
              $40.91
            Offen:
              $40.93
            24-Stunden-Volumen:
                185.04K
            Relative Volume:
              0.83
            Marktkapitalisierung:
                $345.77M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-81.17M
            KGV:
              -3.6332
            EPS:
                -10.1344
            Netto-Cashflow:
                $-82.84M
            1W Leistung:
              -6.97%
            1M Leistung:
              -20.34%
            6M Leistung:
                +75.88%
            1J Leistung:
              -36.69%
            Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
                  
                      Korro Bio Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-468-1999
                    
                Adresse
                  
                      60 FIRST STREET, CAMBRIDGE
                    
                Vergleichen Sie KRRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                KRRO
                            
                             
                        Korro Bio Inc 
                           | 
                    36.82 | 384.18M | 0 | -81.17M | -82.84M | -10.13 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy | 
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy | 
| 2024-08-14 | Eingeleitet | William Blair | Outperform | 
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy | 
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform | 
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy | 
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight | 
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral | 
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform | 
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral | 
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy | 
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform | 
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral | 
| 2019-10-28 | Eingeleitet | Cowen | Outperform | 
| 2019-10-28 | Eingeleitet | Goldman | Buy | 
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight | 
                    Alle ansehen
                    
                  
                Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Will Korro Bio Inc. stock benefit from automationMarket Performance Summary & Verified Technical Signals - newser.com
Custom strategy builders for tracking Korro Bio Inc.2025 Big Picture & Entry Point Confirmation Signals - newser.com
Will Korro Bio Inc. stock recover faster than marketRisk Management & Weekly Stock Performance Updates - newser.com
Can Korro Bio Inc. stock hit record highs againSwing Trade & Advanced Technical Analysis Signals - newser.com
What indicators show strength in Korro Bio Inc.Earnings Risk Report & Precise Trade Entry Recommendations - newser.com
What makes Korro Bio Inc. stock attractive to growth funds2025 Dividend Review & Weekly Market Pulse Updates - newser.com
How to track smart money flows in Korro Bio Inc.Weekly Trend Report & Smart Money Movement Alerts - newser.com
Automated trading signals detected on Korro Bio Inc.Quarterly Profit Review & Short-Term High Return Ideas - newser.com
What is the fair value of Korro Bio Inc. stock nowJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Trend analysis for Korro Bio Inc. this weekMarket Volume Summary & AI Enhanced Trading Signals - newser.com
Can Korro Bio Inc. stock double in next 5 yearsMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Korro Bio Inc.2025 Price Momentum & High Return Stock Watch Alerts - newser.com
What high frequency data says about Korro Bio Inc.Analyst Upgrade & Technical Pattern Based Signals - newser.com
Is Korro Bio Inc. stock positioned for long term growthJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
Why Korro Bio Inc. stock is favored by pension fundsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Published on: 2025-11-01 04:19:56 - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Korro Bio Inc. stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Clear Street Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Key resistance and support levels for Korro Bio Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Will Korro Bio Inc. stock attract more institutional investorsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Clear Street initiates Korro Bio stock with Buy rating, $93 price target - Investing.com Canada
Clear Street initiates Korro Bio stock with Buy rating, $93 price target By Investing.com - Investing.com South Africa
What analysts say about Korro Bio Inc stockInflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):